Description
Dasatinib (Sprycel®) use in daily clinical practice: a Belgian observational retrospective study in patients with chronic myeloid leukaemia and Philadelphia positive acute lymphatic leukaemia who are resistant or intolerant to prior therapies including imatinib
Reviews
There are no reviews yet.